Protein Production Technology Podcast · FPG Media

Episode 34: What’s At Stake When Sustainable Food Isn’t Safe? in Partnership with Merck

·1 hr 1 min·3 clips

Ida Sondergaard calls alternative protein testing “in the infancy stages” and compares a recall to a brand-wide trust shock.

The episode opens by welcoming regular attendees and first-time listeners and framing Protein Production Technology International as a digital hub for the alternative protein value chain, from early-stage research and process development through commercial scale-up and market launch. It then turns to the central question of what is at stake when sustainable food is not safe. The discussion stays grounded. The guest explains that small startups do not have unlimited manpower or complete knowledge, so they have to spot blind spots and bring in know-how to make regulatory safety, food quality, safe production, logistics, and warehouse handling work together. There is no luxury of handling one piece at a time. The work happens all at once, which can also give a startup some flexibility and speed if something needs to change. When the host asks how to bring regulatory and safety thinking into product development early, the answer is that reading regulations helps but is not enough. Some of the important judgment comes from interpretation and from details that are not written down line by line. That is why the conversation keeps returning to expertise. Founders and scientists may be strong on invention, but they still need people who can spot the holes in the process. The episode argues for a mix of in-house and consultant support. An internal regulatory or quality person can understand the whole process and find the gaps, while outside experts can add specialized know-how. The tone stays measured and industry-facing throughout, with a steady focus on how sustainable protein can be safe, credible, and ready for market launch.

As heard by us

Alternative proteins, safety, and early regulatory know-how are the core of this discussion.

Alternative proteins set the frame, but the episode spends most of its time on the unglamorous parts of making that work: regulation, quality, logistics, warehouse handling, and the blind spots that can turn into product risk. Its real value is practical.

Read the full review in PlayNext →

Why you'd press play

If you want a grounded look at alternative-protein startup safety.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Protein Production Technology Podcast